Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.0%

- Check15 days agoChange DetectedEnrollment figures and key study dates were updated (e.g., 429 and dates like 2019-01-24, 2025-03-11, and 2026-02-04), and the interim safety/efficacy data through 06 February 2024 was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedNo additions or deletions are visible; the two screenshots show the same page content.SummaryDifference0.0%

- Check30 days agoChange DetectedA metadata revision updated from v3.4.1 to v3.4.2. This change does not affect the study content or how the page functions.SummaryDifference0.0%

- Check38 days agoChange DetectedA minor version update from v3.4.0 to v3.4.1 with no visible changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedMinor UI and metadata updates were made, including adding a Show glossary option and updating QC-related labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) to Revision: v3.4.0. The previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the older revision (v3.3.4) appear to have been replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.